Atorvastatin: A potential chemopreventive agent in bladder cancer

Ashish M. Kamat; Gina M. Nelkin

doi:10.1016/j.urology.2005.06.075

ScienceGate Book Chapters

JOURNAL ARTICLE

Atorvastatin: A potential chemopreventive agent in bladder cancer

Ashish M. Kamat Gina M. Nelkin

Year: 2005 Journal: Urology Vol: 66 (6)Pages: 1209-1212 Publisher: Elsevier BV

DOI: 10.1016/j.urology.2005.06.075

Get Full-Text PDF Get Analytical Report

Keywords:

Bladder cancer Atorvastatin Medicine Apoptosis DNA fragmentation Propidium iodide Cancer research HMG-CoA reductase Cell growth Cytotoxicity Reductase Cancer Cancer cell Internal medicine Pharmacology Oncology Endocrinology Programmed cell death Biochemistry Biology Enzyme In vitro

Metrics

Cited By

0.88

FWCI (Field Weighted Citation Impact)

Refs

0.73

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cancer, Lipids, and Metabolism

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Lipoproteins and Cardiovascular Health

Health Sciences → Medicine → Surgery

Peroxisome Proliferator-Activated Receptors

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Atorvastatin: A potential chemopreventive agent in bladder cancer

Metrics

Citation History

Topics

Related Documents

589: Atorvastatin: Potential for Use as an Anti-Tumor Agent in Bladder Cancer

Resveratrol: A potential chemopreventive agent in human gastric cancer

319: Effect of Valproic Acid as a Potential Chemopreventive Agent in Animal Models of Bladder Cancer

Myristicin: a potential cancer chemopreventive agent from parsley leaf oil

Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer